Swoop® Portable MR Imaging® System

The Swoop® Portable MR Imaging® System provides ultra-low field magnetic resonance imaging of the head for point-of-care diagnostics, especially when comprehensive exams are impractical. It employs deep learning for enhanced image reconstruction across standard sequences (T1W, T2W, FLAIR, DWI) and incorporates software modifications to pulse sequences and quality control features.

The Swoop® Portable MR Imaging® System is an ultra-low field magnetic resonance imaging device specifically designed for portability and point-of-care use. Its primary purpose is to produce images displaying the internal structure of the head for adult and pediatric patients, particularly in scenarios where a full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide crucial information that can aid in determining a diagnosis across various healthcare settings, including emergency rooms, intensive care units, hospitals, and outpatient or rehabilitation centers. The system operates using standard magnetic resonance imaging contrasts such as T1-weighted (T1W), T2-weighted (T2W), FLAIR, and Diffusion-Weighted Imaging (DWI) sequences, with its image reconstruction algorithm leveraging deep learning to enhance image quality. Users interact with the Swoop system via a commercial off-the-shelf tablet, which controls patient data management, exam setup and execution, image viewing for quality control, and cloud storage interactions. The recent modifications detailed involve software updates primarily affecting its pulse sequences and system quality control test features, which have undergone non-clinical performance testing, including software verification, image performance evaluation against NEMA and ACR standards, and cybersecurity assessments to ensure safety and effectiveness.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the 63.3 mT field strength specifically impact the signal-to-noise ratio and spatial resolution for different sequences (T1W, T2W, FLAIR, DWI) compared to conventional high-field MRI systems?; What are the quantitative metrics used to demonstrate "improved image quality" due to the deep learning reconstruction algorithm, and how do these metrics correlate with diagnostic confidence for specific neuropathologies?; Could you elaborate on the specific software modifications to the "pulse sequences" and how these changes aim to enhance either image acquisition speed, contrast, or artifact reduction in the ultra-low field environment?; What are the typical scan times for the T1W, T2W, FLAIR, and DWI sequences on the Swoop system, and how do these compare to predicate or standard MRI protocols, especially in time-sensitive clinical situations?; Beyond phantom testing, what evidence supports the system's diagnostic utility and reliability across the diverse "professional health care facilities" mentioned in the environment of use, considering potential variations in ambient electromagnetic interference?